A Study to Evaluate the Safety, Tolerability and Efficacy of Multiple Doses of JS002 in Patients With Hyperlipidemia..
Clinical trial NCT04469673 · COMPLETED
Trial details
- NCT number
- NCT04469673
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-23
- Primary completion
- 2020-05-03
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.